Medical Science Liaison
ITF Therapeutics
Medical Science Liaison
ITF Therapeutics
Develops and commercializes rare-disease therapies
About This Role:
The Medical Science Liaison (MSL) is a field-facing role focused on developing and maintaining professional clinical/scientific relationships with external medical experts including pediatric neurologists, neuromuscular specialists, and neurologists, who are involved in the treatment of Duchenne muscular dystrophy.
As the clinical and medical expert on the company’s products and therapeutic areas, our MSLs build long-term relationships and establish rapport with clinicians in hospitals, clinics, and academic centers through highly scientific product and disease state discussions that support the safe and effective utilization of ITF’s therapies.
This position will play a key role in supporting ITF’s medical affairs goals by contributing to internal initiatives such as ad boards, speaker training, and clinical insights projects.
The ideal candidate brings a strong foundation in rare neuromuscular diseases, with a preference for prior experience in DMD. Comfort navigating complex scientific conversations, working autonomously in the field, and contributing to a collaborative and close-knit medical affairs team is essential.
This role supports care centers in KS, MO, NE, IA, SD, ND, MN, WI, and IL
What You'll Do:
Who You Are:
You are an experienced professional with a passion for building and sustaining trusted clinical and scientific relationships with external medical experts. You have a strong track record of designing and delivering engaging, informative training programs that keep teams aligned with the latest medical insights and industry best practices. You bring an analytical mindset and excellent problem-solving skills, allowing you to adapt quickly to changing priorities and deadlines. With a solid understanding of the pharmaceutical delivery process, you consistently operate in a compliant and ethical manner within a highly regulated industry.
Required Skills:
Preferred Skills:
Additional Information:
The base compensation range for this role is $185,000 - $220,000. Compensation is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
In addition to compensation, ITF offers a full and highly competitive range of benefits designed to support our employees’ and their families’ physical, financial, emotional, and social well-being, including, but not limited to:
Develops and commercializes rare-disease therapies
ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.
Explore more opportunities at ITF Therapeutics